Together with 12 de novo PTVs of MSL2 curated from 3 large cohorts of clinical genetic testing or research studies, our finding provides strong support for a pathogenic role PTVs of MSL2 in NDD and ASD. The gene discussed is MSL2; the disease is Neurodevelopmental delay.